ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD.
Search, find, compare suppliers for anti-ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) |
| Clone | Rovelizumab |
| Host Species | Recombinant |
| Reactive Species | human |
| Isotype | IgG4 |
| Format | purified |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Applications | n/a |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody. Rovelizumab, also known as LeukArrest and Hu23F2G, is a humanized monoclonal antibody which was an experimental immunosuppressive drug. Rovelizumab was developed by Icos to treat patients suffering from haemorrhagic shock. The drug is a monoclonal antibody that suppresses white blood cells which become overly active during shock. |
| Immunogen | n/a |
| Other Names | Anti-ITGAL & CD11a & CD18 Recombinant Antibody, Research Grade Rovelizumab, Anti-Human ITGAL & CD11a & CD18 Recombinant Antibody, Hu23F2G, Antibody Drug Analogues, Monoclonal Antibody, YR1202, Research Grade Biosimilars, Biosimilar Antibody |
| Gene, Accession # | CAS: 339086-79-2 |
| Catalog # | YR1202 |
| Price | please inquire |
| Order / More Info | ITGAL & CD11a & CD18, Human (Rovelizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
| Product Specific References | n/a |
KMD BIOSCIENCE CO. LTD.
KMD BIOSCIENCE CO. LTD.
FL-4, Building A5
International Enterprise Community
Tianjin CHINA
P: 400-621-6806
info@kmdbioscience.com
Sales: sales@kmdbiosci.com
https://www.kmdbioscience.com
Profile of KMD BIOSCIENCE CO. LTD.